Serum hemato-immunological biomarkers associated with increased COVID-19 mortality in the Latino population

Biomark Med. 2022 Jul;16(10):799-810. doi: 10.2217/bmm-2022-0056. Epub 2022 May 16.

Abstract

Introduction: COVID-19 hospitalizations and deaths have raised the need of identifying prognostic factors for medical decision-making. Methods: Observational, retrospective study analyzing 191 COVID-19 patients' serum inflammatory biomarkers. Results: The median age was 48.7 ± 12.7 years, 75.9% being men. Overweight/obesity was the most common comorbidity in 83.8% of patients. 44.5% had moderate disease followed by 43.5% with severe disease. The mean percentage of pulmonary damage was 53.4% ± 28.7. Serum leukocyte-to-lymphocyte ratio >7.7, neutrophil-to-lymphocyte ratio >10, platelet-to-lymphocyte ratio ≥250 and nutritional index <362 all were independent mortality predictors for COVID-19. Conclusions: A leukocyte-to-lymphocyte ratio >7.7 as well as a nutritional index <362 at hospitalization were independently associated with an increased mortality.

Keywords: COVID-19; inflammatory biomarkers; mortality; prognostic factors.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Biomarkers
  • COVID-19*
  • Female
  • Hispanic or Latino
  • Humans
  • Male
  • Middle Aged
  • Neutrophils
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers